Predict your next investment

HEALTHCARE | Medical Facilities & Services / Hospitals

See what CB Insights has to offer

Investors Count

1

Deal Terms

1

Nantong Hemeijia Funding, Nantong Hemeijia Valuation & Nantong Hemeijia Revenue

1 Fundings

Nantong Hemeijia's latest funding round was a Corporate Majority for $44.1M on July 10, 2017.

Nantong Hemeijia's latest post-money valuation is from July 2017.

Sign up for a free trial to see Nantong Hemeijia's valuations in July 2017 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/10/2017

Corporate Majority

$44.1M

$99M

1

Date

7/10/2017

Round

Corporate Majority

Amount

$44.1M

Investors

Valuation

$99M

Revenue

Sources

1

Nantong Hemeijia Deal Terms

1 Deal Term

Nantong Hemeijia's deal structure is available for 1 funding round, including their Corporate Majority from July 10, 2017.

Round

Corporate Majority

Funding Date

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Corporate Majority

$99M

$99M

$99M

$99M

$99M

$99M

Nantong Hemeijia Investors

1 Investors

Nantong Hemeijia has 1 investors. HarMoniCare Medical invested in Nantong Hemeijia's Corporate Majority funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/10/2017

7/10/2017

1
Corporate Majority

Corporation

China

First funding

7/10/2017

Last Funding

7/10/2017

Investor

Rounds

1
Corporate Majority

Board Seats

Type

Corporation

Location

China

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.